T-MAC Co., Ltd

MiRIA System
· System 1 : High-efficiency immunoblot technology using multiple samples · System 2 : High-efficiency immunoblot technology using multiple antibodies Sales of consumables and automation equipment for MiRIA system implementation Sample analysis service using MiRIA system and T-Mac antibody collection

Development of MiRIA system automation equipment
· Development of CDR antibody reactors for MiRIA system 1 Reduction of antibody reaction time, antibody consumption · Development of automatic antibody reactors for MiRIA System 2 Increased efficiency and user convenience by automating multiple-antibody reactions · Fluorescent scanner development Analysis of immunoblot images using fluorescent tags

Antibody collection
· Doubt about the reliability of commercial antibodies (GEN 36, 21; BioTechique 48: 197-209) Development and sale of analytical sample collections for antibody verification · Limitations of studies using various antibodies due to high antibody prices Sale and service of many and small amount of antibody collection

New antibody development
· Most of the research antibodies were developed for humans and certain model mammals Antibody demand for research on microorganisms, plants, etc. · New antibody demand for protein function research Antibody collection supplement · Securing competitiveness by introducing the latest antibody development technology (Single antibody technology, recombinant antibody technology) · Joint research with the Korea Research Institute of Bioscient & Biotechnology

New antibody development

· Most of the research antibodies were developed for humans and certain model mammals
Antibody demand for research on microorganisms, plants, etc.
· New antibody demand for protein function research Antibody collection supplement
· Securing competitiveness by introducing the latest antibody development technology (Single antibody technology, recombinant antibody technology)
· Joint research with the Korea Research Institute of Bioscient & Biotechnology

Biomarker
· Biomarker development platform based on protein function (protein modification, intracellular protein transfer) · Enhanced analysis efficiency using MiRIA and antibody collection · In the post-genome era, protein biomarkers are highlighted as a major means of accelerating the personalized medicine era · The discovery of biomarkers is expected to significantly improve the productivity of new drug development by dramatically shortening the R&D cost and period related to systematization of new drug development process. · Increased need for biomarkers to explore proteins linked to major biological pathways in relation to disease development and progression and to be applied to predictive diagnostics through the search and verification of standard proteins to be used for drug toxicity analysis and development of alternative drugs for clinical use · Increased need for biomarker research through efforts to shift the current medical system based on treatment to diagnosis centered medical system

Biomarker

· Biomarker development platform based on protein function (protein modification, intracellular protein transfer)
· Enhanced analysis efficiency using MiRIA and antibody collection
· In the post-genome era, protein biomarkers are highlighted as a major means of accelerating the personalized medicine era
· The discovery of biomarkers is expected to significantly improve the productivity of new drug development by dramatically shortening the R&D cost and period related to systematization of new drug development process.
· Increased need for biomarkers to explore proteins linked to major biological pathways in relation to disease development and progression and to be applied to predictive diagnostics through the search and verification of standard proteins to be used for drug toxicity analysis and development of alternative drugs for clinical use
· Increased need for biomarker research through efforts to shift the current medical system based on treatment to diagnosis centered medical system

Immunodiagnosis
· Increased productivity and efficiency of strips compared to commercial WB-Line Blot through MiRIA technology · Reduction of diagnostic time through CDR technology action · Internalization of antibodies for immunodiagnosis through single antibodyl and recombinant antibody technology · Much larger immune diagnosis market than molecular diagnostic analysis market

21st century bio leading company

Development roadmap A company for happy life of mankind & 21st century bio leading company